Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

Clinical trial NCT02449603 · COMPLETED

Trial details

NCT number: NCT02449603
Sponsor: Xijing Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2015-11-01
Primary completion: 2018-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.